Skip to main content
. 2012 Aug 3;7(8):e42134. doi: 10.1371/journal.pone.0042134

Table 8. Plasma creatinine, BUN, lipase, ALT and AST levels at the end of treatment.

Treatment Creatinine (mg/dL) BUN (mg/dL) Lipase (U/L) ALT (U/L) AST (U/L)
Lean Veh 0.32±0.01 18.5±0.7 76±12 54±14* 64±6*
DIO Veh 0.35±0.01 16.1±0.9 86±2 125±11 106±12
CB1 ASO 25 mg/kg/wk 0.33±0.00 14.9±0.9 70±4 80±6* 103±12
CB1 ASO 12.5 mg/kg/wk 0.36±0.02 17.5±1.5 89±5 122±10 138±32
CB1 ASO 6.25 mg/kg/wk 0.33±0.01 15.9±0.3 97±10 103±15 85±9
Control ASO 25 mg/kg/wk 0.47±0.13 17.1±0.3 90±2 73±7* 71±5*

Values shown are mean ± se. One way ANOVA Dunnett’s multiple test compared to DIO Veh, *p<0.05.